Evidence map›Paper›PMID 32984856›Full record

ArticleCell reports. Medicine2020

Programming Multifaceted Pulmonary T Cell Immunity by Combination Adjuvants.

Chandranaik B Marinaik, Brock Kingstad-Bakke, Woojong Lee, Masato Hatta, Michelle Sonsalla, Autumn Larsen, Brandon Neldner, David J Gasper, Ross M Kedl, Yoshihiro Kawaoka and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports. Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Chandranaik B MarinaikDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA.
Brock Kingstad-BakkeDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA.
Woojong LeeDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA.
Masato HattaDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA.
Michelle SonsallaDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA.
Autumn LarsenDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA.
Brandon NeldnerDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA.
David J GasperDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA.
Ross M KedlDepartment of Immunology and Microbiology, School of Medicine, University of Colorado, Aurora, CO, USA.
Yoshihiro KawaokaDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA.
M SureshDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA.
University of Wisconsin–Madison · USUniversity of Colorado Anschutz Medical Campus · US

Funding

Novel Combination Adjuvant for Eliciting Systemic and Mucosal CD8 T Cell MemoryU01AI124299 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI KLEIN, BRUCE STEVEN, SURESH, MARULASIDDAPPA · 2016 to 2025
$6.2M
Comparative Biomedical Sciences Training ProgramT32OD010423 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI Marulasiddappa Suresh · 2012 to 2026
$5.0M
Mucosal Adjuvant to Induce Multipronged T Cell Immunity to TuberculosisR21AI149793 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI SURESH, MARULASIDDAPPA · 2020 to 2021
$427k
NIAID NIH HHS R21 AI149793NIAID NIH HHS U01 AI124299NIH HHS T32 OD010423
6 · The paper itself

Abstract

Induction of protective mucosal T cell memory remains a formidable challenge to vaccinologists. Using a combination adjuvant strategy that elicits potent CD8 and CD4 T cell responses, we define the tenets of vaccine-induced pulmonary T cell immunity. An acrylic-acid-based adjuvant (ADJ), in combination with Toll-like receptor (TLR) agonists glucopyranosyl lipid adjuvant (GLA) or CpG, promotes mucosal imprinting but engages distinct transcription programs to drive different degrees of terminal differentiation and disparate polarization of T

Indexed as

Acrylic ResinsAdjuvants, VaccineAnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell DifferentiationInflammationInfluenza A virusInfluenza VaccinesIntraepithelial LymphocytesLungMemory T CellsMiceOrthomyxoviridae InfectionsReceptors, Antigen, T-CellSignal TransductionAcrylic ResinsAdjuvants, VaccinecarbomerInfluenza VaccinesReceptors, Antigen, T-CellToll-Like ReceptorsadjuvantsCD4CD8heterosubtypicinfluenza virusmucosal subunit vaccinesrespiratory immunityT1 and T17 programmingtissue-resident memory

Identifiers

PMID32984856
PMCPMC7508055
OpenAlexW3087315870

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.